Despite the increase in cash burn, the company's solid cash runway and the analysts' forecast of reaching breakeven point suggest a positive outlook. The company's cash burn relative to its market capitalisation, which is US$1.4b, is about 1.7%, indicating that it could potentially raise more cash easily if needed.
Is it Nvidia, the maker of chips related to artificial intelligence? This is despite the fact that the stock has soared more than 200% this year. Other big tech stocks like Apple are up nearly 50% this year, Microsoft is up about 56%, Google parent Alphabet's Class A and Class C shares are up nearly 60% each, Amazon is up more than 80%, Tesla has doubled more than doubled, and Meta almost tripled. However, none of these stoc...
The substantial share sale by President Anish Bhatnagar and the absence of insider purchases over the last year could signify uncertainty about the company's future. While insider ownership hints at certain alignment with shareholder interests, historical sales ignite cautiousness.
Insider selling of Soleno shares, particularly by Jack Schuler, may imply insiders see the shares as fully valued at lower prices. The insider ownership in Soleno Therapeutics isn't notably high, indicating perhaps a lack of insider belief in the company.
$Celularity(CELU.US)$slno went crazy rmb ? and probably they can send this to 1+ too , the float is quite high but as long as the company is decent , it is ok with 100m float with good ownership $Soleno Therapeutics(SLNO.US)$slno get beaten down after rs and get his revenge force short to cover with huge loss
$Soleno Therapeutics(SLNO.US)$on 02 Oct closed their public offering of 3,450,000 shares of its common stock at a public offering price of $20.00 per share. The gross proceeds of the public offering were $69.0 million. The last time they raised equity capital in September 2023, their share price surge, hence, it should be this time that we will see Soleno share price rise again this week after their offering closed on 02 Oct. In this article I will be ...
Soleno Therapeutics股票讨论区
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings(CERE.US)$
$爱美医疗(FOLD.US)$
$Iovance Biotherapeutics(IOVA.US)$
$Arcellx(ACLX.US)$
$Nuvalent(NUVL.US)$
$Apogee Therapeutics(APGE.US)$
$Inhibrx(INBX.US)$
$Fusion Pharmaceuticals(FUSN.US)$
$Rhythm Pharmaceuticals(RYTM.US)$
$Vaxcyte(PCVX.US)$
$Soleno Therapeutics(SLNO.US)$
$美敦力(MDT.US)$
$Madrigal Pharmaceuticals(MDGL.US)$
...
Now they have a way to treat diabetes, obesity. I believe later they will find a way to cure cancer, Alzheimer and other disease not just treat it and prevent it.
To clone something is unreal before, even travel to mars is real now. ( $维珍银河(SPCE.US)$
thank you for wonderful run $Tempest Therapeutics(TPST.US)$ $Soleno Therapeutics(SLNO.US)$ $Arcutis Biotherapeutics(ARQT.US)$ $2seventy bio(TSVT.US)$ $Redhill Biopharma(RDHL.US)$ etc... th...
However, none of these stoc...
$Soleno Therapeutics(SLNO.US)$ slno get beaten down after rs and get his revenge force short to cover with huge loss
The last time they raised equity capital in September 2023, their share price surge, hence, it should be this time that we will see Soleno share price rise again this week after their offering closed on 02 Oct.
In this article I will be ...
暂无评论